Brought to you by 
Ascend and AEterna Zentaris enter co-promotion/product swap for EstroGel, Macrilen
27 Aug 2014
Executive Summary
AEterna Zentaris Inc. (cancer and endocrinology therapies) and women’s health company Ascend Therapeutics US LLC agreed to co-promote certain products of the other’s in the US. The partners will receive commissions from each other on sales of the swapped therapies.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Intra-Biotech Deal
- Marketing (Licensing)
- Product or Technology Swap
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ascend and AEterna Zentaris enter co-promotion/product swap for EstroGel, Macrilen
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice